David__C__A Profile Banner
David Castillo-Azofeifa Profile
David Castillo-Azofeifa

@David__C__A

Followers
721
Following
957
Media
49
Statuses
264

Principal Scientist/Group Leader @genentech, interested in the diverse regenerative strategies of tissues and how they fail later in life. From CR 🇨🇷

South San Francisco, CA
Joined November 2017
Don't wanna be here? Send us removal request.
@David__C__A
David Castillo-Azofeifa
2 years
Perplexity and then… eureka! Could a cytokine predominantly associated with cell death and inflammation regulate cell differentiation and mucus? In our most recent paper @jclinicalinvest, we address this question. Check out the paper https://t.co/X3VCMeYaX9 Summary 🧵⬇️
4
8
36
@David__C__A
David Castillo-Azofeifa
5 months
Huge congrats to the whole team! A special shout-out to Tony Korcari, Helen Tauc, and Jeff Duggan for spearheading this work.
0
0
1
@David__C__A
David Castillo-Azofeifa
5 months
Our new preprint: https://t.co/VVV0ThnHy3 IFNγ is a double-edged sword for gut regeneration. Young guts: transient burst heals. Aged guts: prolonged upregulation impairs repair by trapping cells in a fetal-like state🔥📉 #immunology #inflammaging #aging #stemcells #regeneration
2
0
11
@David__C__A
David Castillo-Azofeifa
7 months
Huge congrats @LabMaxYav and @AnsethGroup 🎉
@AnsethGroup
Anseth Group
8 months
🎆🎇 Congrats to @LabMaxYav for his new paper, "Engineered epithelial curvature controls Paneth cell localization in intestinal organoids," out now in @CellBiomat. Max explored how local matrix curvature influences differentiation of confined intestinal organoids — link below!
0
0
4
@David__C__A
David Castillo-Azofeifa
1 year
So cool to see this story out. Congrats!!! 🎉
@jimmy_k_hu
Jimmy Hu
1 year
Excited to share our new paper @PLOSGenetics that reveals how Shh signaling promotes myosin II activity to regulate tooth morphogenesis in mice!
0
0
3
@Fusion_Conf
Fusion Conferences
2 years
The sun is out for Day 3 of #Stemgastro24. Many exciting talks to look forward to with the poster awards & gala dinner this evening 🕺💃
2
14
33
@David__C__A
David Castillo-Azofeifa
2 years
Fantastic 1st day #Stemgastro24 @Fusion_Conf
1
3
15
@David__C__A
David Castillo-Azofeifa
2 years
View of the #Bay from the lab 🤩 Yamini, thanks for sharing it 👏
1
0
23
@David__C__A
David Castillo-Azofeifa
2 years
Congrats @RKZwick, @OphirKlein and collaborators!!!! 🎉 The small intestine is organized in 5, yes 5, metabolic domains. Fantastic work! Check it out!
@RKZwick
Rachel Zwick
2 years
Our work to define the regional organization of the small intestine is online @NatureCellBio today: https://t.co/pjnlnXMuB9!! Make way for domains A – E and a new approach to track the molecular patterns of nutrient metabolism. Many thanks to @s_lefkopoulos & our reviewers!
1
4
7
@David__C__A
David Castillo-Azofeifa
2 years
As we closed a fantastic year, we wish all the best for 2024 🎉 Pic below: End of Year Celebration @LlucMosteiro lab + Castillo-Azofeifa lab
0
1
11
@David__C__A
David Castillo-Azofeifa
2 years
It was so much fun having @Yueming_L as an intern this summer in the lab mentored by Yamini Nanduri. I very much enjoyed the great discussions and data on mechanotransduction and hydrogels 👏 Best wishes on your PhD studies in the @heilshornlab
1
0
7
@David__C__A
David Castillo-Azofeifa
2 years
It was a great privilege to be part of Efren’s PhD mentoring team with @OphirKlein and @ZevGartner and collaborate with @JeremieRispal and everyone involved in this project
0
0
2
@David__C__A
David Castillo-Azofeifa
2 years
(11/11) Here, we revealed new roles for TNF in intestinal cell differentiation and modulation of CFTR activity with implications in future interventions for IBD using anti-TNF therapy
1
0
1
@David__C__A
David Castillo-Azofeifa
2 years
(10/11) Using samples from donors: ➡️IBD non-inflamed ➡️IBD undergoing anti-TNF therapy ➡️Healthy We found that non-inflamed tissue and healthy donors had a similar proportion of goblet cells, whereas patients treated with anti-TNF had a higher proportion of crypt goblet cells
1
0
0
@David__C__A
David Castillo-Azofeifa
2 years
(9/11) Clinically relevant, elevated TNF levels associated with inflammatory bowel disease (IBD) can lead to decreased goblet cell numbers. And patients with cystic fibrosis are 7 times more likely to have IBD. Could IBD patients treated with anti-TNF have increased goblet cells?
1
0
0
@David__C__A
David Castillo-Azofeifa
2 years
(8/11) Using various genetic and pharmacological tools, we demonstrated that epithelial TNF-TNFR1 interactions control mucin flux via CFTR-induced fluid pumping
1
0
0
@David__C__A
David Castillo-Azofeifa
2 years
(7/11) Interestingly, cystic fibrosis patients with dysfunctional CFTR exhibit accumulation of mucin, increased bacterial load, and slow gut motility. Therefore, we asked if epithelial TNF acts as an upstream regulator of CFTR in addition to regulating epithelial differentiation
1
0
0
@David__C__A
David Castillo-Azofeifa
2 years
(6/11) There are various sources of TNF in the intestine. Thus, we explored if TNF expressed by the epithelium is required for mucin homeostasis. We determine that epithelial-derived TNF regulates mucin homeostasis, in part by inhibiting secretory progenitor bias to goblet cells
1
0
0
@David__C__A
David Castillo-Azofeifa
2 years
(5/11) We discovered that TNF does not affect secretory cell turnover but controls goblet cell number by regulating secretory progenitor cell differentiation
1
0
0
@David__C__A
David Castillo-Azofeifa
2 years
(4/11) Next, we evaluated the role of TNF in mucin homeostasis by analyzing Tnf −/− mice. TNF null intestines had increased luminal mucin, goblet cell numbers, intestinal transit time, and bacterial load, which we propose results from an increase in mucus-producing goblet cells
1
0
0
@David__C__A
David Castillo-Azofeifa
2 years
(3/11) We first characterized the expression pattern of TNF and its receptors in the intestine. We found that TNF, TNFR1, and TNFR2 are expressed in defined spatial domains along the crypt-villus axis
1
0
0